We performed an extensive evaluation of the expression profiles of established markers for HCC stem cells, including CD133, CD24, CD326, CD90, CD44, and CD338, in the HepG2, Huh7, and PLC/PRF/5 cell lines. This evidence concerns the gene CD44 and hepatocellular carcinoma.